Laxative

Label at a glance#

Contacts and useful links#

Label contents#

Full prescribing information#

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Sennosides USP, 25 mg

Purpose

OTC - PURPOSE SECTION

Stimulant laxative

Uses

INDICATIONS & USAGE SECTION

• relieves occasional constipation (irregularity)
• generally produces bowel movement in 6 to 12 hours

Warnings

WARNINGS SECTION

Do not use

OTC - DO NOT USE SECTION

laxative products when abdominal pain, nausea, or vomiting are present unless directed by a doctor. 

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

• noticed a sudden change in bowel habits that persists over a period of 2 weeks

Ask a doctor or pharmacist before use if you

OTC - ASK DOCTOR/PHARMACIST SECTION

• are taking any other drug. Laxatives may affect how other drugs work. Take this product 2 or more hours before or after other drugs.

When using this product

OTC - WHEN USING SECTION

• do not use for a period longer than 1 week

Stop use and ask a doctor if

OTC - STOP USE SECTION

• rectal bleeding or failure to have a bowel movement occur after use of a laxative

These may be signs of a serious condition.

If pregnant or breast feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use. 

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Posion Control Center right away. 

Directions

DOSAGE & ADMINISTRATION SECTION

• swallow tablet(s) with a glass of water
• swallow tablet(s) whole, do not crush, break, or chew

adults and children 12 years of age and older	take 2 tablets once or twice daily
children 6 to under 12 years of age	take 1 tablet once or twice daily
children under 6 years of age	ask a doctor

Other information

STORAGE AND HANDLING SECTION

• each tablet contains: calcium 40 mg
• very low sodium
• store between 20-25ºC (68-77ºF)

Inactive ingredients

INACTIVE INGREDIENT SECTION

acacia, calcium phosphate dihydrate, calcium sulfate anhydrous*, carnauba wax, corn starch*, croscarmellose sodium, FD&C blue #1 aluminum lake,  iron oxide*, iron oxide black, iron oxide yellow*, kaolin, magnesium stearate, maltodextrin, microcrystalline cellulose,  polyethylene glycol, povidone*, shellac, silicon dioxide*, stearic acid*, sugar, talc, titanium dioxide

Questions or comments?

OTC - QUESTIONS SECTION

Call toll free 1-877-932-7948 

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

compare to ex-lax® Maximum Strength active ingredient†

maximum strength

Laxative

Sennosides USP, 25 mg

(stimulant laxative)

gentle, dependable overnight relief

tablets

†This product is not manufactured or distributed by GlaxoSmithKline plc, distributor of ex-lax®

TAMPER EVIDENT: DO NOT USE IF BLISTER UNIT IS TORN, BROKEN OR SHOWS ANY SIGNS OF TAMPERING.

KEEP OUTER CARTON FOR COMPLETE WARNINGS AND PRODUCT INFORMATION

DISTRIBUTED BY SUPERVALU INC., EDEN PRAIRE, MN 55344 USA

Product Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

FDA-Initiated Inactive NDC Indexing#

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 25 matching rows.

• Laxative Maximum Strength
• Sennosides
• ACACIA
• CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
• CALCIUM SULFATE ANHYDROUS
• CARNAUBA WAX
• STARCH, CORN
• CROSCARMELLOSE SODIUM
• FD&C BLUE NO. 1
• FERRIC OXIDE RED
• FERROSOFERRIC OXIDE
• FERRIC OXIDE YELLOW
• KAOLIN
• MAGNESIUM STEARATE
• CELLULOSE, MICROCRYSTALLINE
• MALTODEXTRIN
• POLYETHYLENE GLYCOL, UNSPECIFIED
• POVIDONE
• SHELLAC
• SILICON DIOXIDE
• STEARIC ACID
• SUCROSE
• TALC
• TITANIUM DIOXIDE
• ALUMINUM OXIDE

NDC Codes#

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 24 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.